CCRP SoCRA Exam
21 CFR Part eleven
Electronic Records; Electronic Signatures
21 CFR Part eleven Subpart B
Electronic Records
21 CFR Part eleven Subpart C
Electronic Signatures
21 CFR Part 50
Protection of Human Subjects
21 CFR Part 50 Subpart B
Informed Consent of Human Subjects
21 CFR Part 50 Subpart D
Additional Safeguards for Children in Clinical Investigations
21 CFR Part fifty six
Institutional Review Board
21 CFR Part fifty six Subpart B
Organization and Personnel
21 CFR Part 56 Subpart C
IRB Functions and Operations
21 CFR Part 56 Subpart D
IRB Records and Reports
, 21 CFR Part fifty six Subpart E
Administrative Actions for Noncompliance
21 CFR Part 312
Investigational New Drug Application
21 CFR Part 312 Subpart B
Investigational New Drug Application (IND)
21 CFR Part 312 Subpart C
Administrative Actions
21 CFR Part 312 Subpart D
Responsibilities of Sponsors and Investigators
21 CFR Part 312 Subpart E
Drugs Intended to Treat Life-Threatening and Severely-Debilitating Illnesses
21 CFR Part 312 Subpart F
Miscellaneous
21 CFR Part 312 Subpart I
Expanded Access to Investigational Drugs for Treatment Use
21 CFR Part 812
Investigational Device Exemptions
21 CFR Part 812 Subpart B
Application and Administrative Action
21 CFR Part 812 Subpart C
Responsibilities of Sponsors
21 CFR Part eleven
Electronic Records; Electronic Signatures
21 CFR Part eleven Subpart B
Electronic Records
21 CFR Part eleven Subpart C
Electronic Signatures
21 CFR Part 50
Protection of Human Subjects
21 CFR Part 50 Subpart B
Informed Consent of Human Subjects
21 CFR Part 50 Subpart D
Additional Safeguards for Children in Clinical Investigations
21 CFR Part fifty six
Institutional Review Board
21 CFR Part fifty six Subpart B
Organization and Personnel
21 CFR Part 56 Subpart C
IRB Functions and Operations
21 CFR Part 56 Subpart D
IRB Records and Reports
, 21 CFR Part fifty six Subpart E
Administrative Actions for Noncompliance
21 CFR Part 312
Investigational New Drug Application
21 CFR Part 312 Subpart B
Investigational New Drug Application (IND)
21 CFR Part 312 Subpart C
Administrative Actions
21 CFR Part 312 Subpart D
Responsibilities of Sponsors and Investigators
21 CFR Part 312 Subpart E
Drugs Intended to Treat Life-Threatening and Severely-Debilitating Illnesses
21 CFR Part 312 Subpart F
Miscellaneous
21 CFR Part 312 Subpart I
Expanded Access to Investigational Drugs for Treatment Use
21 CFR Part 812
Investigational Device Exemptions
21 CFR Part 812 Subpart B
Application and Administrative Action
21 CFR Part 812 Subpart C
Responsibilities of Sponsors
